| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Apr―25 |
Additional insights on SARS-CoV-2 spike protein variants and red blood cells biology |
Francesco Dima, Gian Luca Salvagno, Giuseppe Lippi |
| 2 |
[GO] |
2025―Apr―22 |
Effect of SARS-CoV2 S protein on red blood cells parameters. Some comments |
Geir Bjørklund, Umberto Tirelli, Salvatore Chirumbolo, Luigi Valdenassi |
| 3 |
[GO] |
2025―Feb―15 |
Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan |
Hao-Yuan Lee, Chih-Hsien Chuang, Chung-Guei Huang, Tzu-Chun Chuang, Yu-An Kung, Cheng-Hsun Chiu |
| 4 |
[GO] |
2024―Nov―26 |
Genomic Surveillance of SARS-CoV-2 in Taiwan: A Perspective on Evolutionary Data Interpretation and Sequencing Issues |
Yu-Nong Gong, Nai-Yu Kuo, Ting-Syuan Yeh, Shin-Ru Shih, Guang-Wu Chen |
| 5 |
[GO] |
2024―Sep―07 |
Effects of recombinant SARS-CoV-2 spike protein variants on red blood cells parameters and red blood cell distribution width |
Francesco Dima, Gian Luca Salvagno, Giuseppe Lippi |
| 6 |
[GO] |
2024―Jul―14 |
Basic implications on three pathways associated with SARS-CoV-2 |
Jong hoon Lee, Consolato Sergi, Richard E. Kast, Badar A. Kanwar, Jean Bourbeau, Sangsuk Oh, Mun-Gi Sohn, Chul Joong Lee, Michael D. Coleman |
| 7 |
[GO] |
2024―Apr―06 |
Blood oxygenation state in COVID-19 patients: Unexplored role of 2,3-bisphosphoglycerate |
Maria Sofia Bertilacchi, Rebecca Piccarducci, Alessandro Celi, Lorenzo Germelli, Chiara Romei, Brian Bartholmai, Greta Barbieri, Chiara Giacomelli, Claudia Martini |
| 8 |
[GO] |
2023―Aug―19 |
Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes |
Iñigo Ximeno-Rodríguez, Irene Blanco-delRío, Egoitz Astigarraga, Gabriel Barreda-Gómez |
| 9 |
[GO] |
2023―Feb―25 |
SARS-CoV-2 pandemics: an update of CRISPR in diagnosis and host-virus interaction studies |
Wen-Fang Tang, Tu Tran Anh, Ling-Yu Wang, Jim-Tong Horng |
| 10 |
[GO] |
2023―Jan―13 |
Race with virus evolution: The development and application of mRNA vaccines against SARS-CoV-2 |
Kuo-Ming Lee, Syh-Jae Lin, Chung-Jung Wu, Rei-Lin Kuo |
| 11 |
[GO] |
2022―Nov―19 |
Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study |
Shu-Min Lin, Allen Chung-Cheng Huang, Tzu-Hsuan Chiu, Ko-Wei Chang, Tse-Hung Huang, Tsung-Hsien Yang, Yi-Hsien Shiao, Chung-Shu Lee, Fu-Tsai Chung, Chyi-Liang Chen, Cheng-Hsun Chiu |
| 12 |
[GO] |
2022―Aug―28 |
Hypocalcemia: a key biomarker in hospitalized COVID-19 patients |
M.J. Ruiz-Álvarez, Emanuela Stampone, Yaiza Fernández Verduras, Giovanni Gallo, Marta Barrionuevo González, Belén Beteré Cubillo, Debora Bencivenga, Fulvio Della Ragione, Adriana Borriello |
| 13 |
[GO] |
2022―Aug―17 |
Prevention and treatment of COVID-19 infection by earthing |
Haider Abdul-Lateef Mousa |
| 14 |
[GO] |
2022―Aug―11 |
Phylogenetic Characteristics of Non-SARS Human Coronavirus in Southern Taiwan, 2012-2013 |
Hsuan-Chen Wang, Yu-Chun Wang, Chi-Jung Wu |
| 15 |
[GO] |
2022―Aug―07 |
Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection |
Maia Lina Elizagaray, Ignacio Mazitelli, Andrea Pontoriero, Elsa Baumeister, Guillermo Docena, Clemente Raimondi, Enrique Correger, Martín Rumbo |
| 16 |
[GO] |
2022―Jun―06 |
Bilateral lentiform and caudate nucleus lesions in a child with COVID-19: A case report |
Nihal Akçay, Figen Bakırtaş Palabıyık, Esra Şevketoğlu |
| 17 |
[GO] |
2022―May―06 |
SARS-CoV-2 Variants - Evolution, Spike Protein, and Vaccines |
Kai-Wei K. Chen, Daniel Tsung-Ning Huang, Li-Min Huang |
| 18 |
[GO] |
2022―Apr―01 |
Novel Approach by Natural Language Processing for COVID-19 Knowledge Discovery |
Li Wang, Lei Jiang, Dongyan Pan, Qinghua Wang, Zeyu Yin, Zijian Kang, Haoran Tian, Xuqiang Geng, Jinsong Shao, Wenjie Pan, Jian Yin, Li Fang, Yue Wang, Weide Zhang, Zhixiu Li, Jun Zheng, Wenxin Hu, Yunbao Pan, Dong Yu, Shicheng Guo, Wei Lu, Qiang Li, Yunyun Zhou, Huji Xu |
| 19 |
[GO] |
2022―Mar―09 |
Time course and epidemiological features of COVID-19 resurgence due to cold-chain food or packaging contamination |
Wenjuan Chen, Chyi-Liang Chen, Qing Cao, Cheng-Hsun Chiu |
| 20 |
[GO] |
2022―Jan―28 |
COVID-19 vaccination uptake strongly predicts averted deaths of older people across Europe |
Camilla Mattiuzzi, Brandon M. Henry, Giuseppe Lippi |
| 21 |
[GO] |
2021―Dec―03 |
Lipopeptides against COVID-19 RNA-dependent RNA polymerase using molecular docking |
Bo Xia, Minyi Luo, Li Pang, Xia Liu, Youjin Yi |
| 22 |
[GO] |
2021―Nov―19 |
Exposure to PM2.5 and PM10 and COVID-19 Infection Rates and Mortality: a one-year observational study in Poland |
Marta Czwojdzińska, Małgorzata Terpińska, Amadeusz Kuźniarski, Sylwia Płaczkowska, Agnieszka Piwowar |
| 23 |
[GO] |
2021―Nov―15 |
Spectrum of neuroimaging mimics in children with COVID-19 infection |
Alex Mun-Ching Wong, Cheng Hong Toh |
| 24 |
[GO] |
2021―Oct―26 |
Infection control operations of a large hospital in Taiwan to prevent nosocomial outbreaks during COVID-19 pandemic |
Chun-Wen Cheng, Po-Yen Huang, Ting-Shu Wu, Chung-Guei Huang, Kuo-Chien Tsao, Chun-Sui Lin, Ting-Ying Chung, Chi-Chun Lai, Cheng-Ta Yang, Cheng-Hsun Chiu |
| 25 |
[GO] |
2021―Oct―19 |
Reply to the comments on letter to the editor on review article “Current Updates and treatment Strategy of the European and WHO Registered Clinical Trials of Coronavirus Disease 2019” |
Henu Kumar Verma, Neha Merchant, L.V.K.S. Bhaskar |
| 26 |
[GO] |
2021―Sep―02 |
“Clinical studies on coronavirus disease 2019 (COVID-19) in the WHO Registry Network” |
Y.M. Castillo-Aleman, Y. Ventura-Carmenate, R.A. Rivero-Jimenez |
| 27 |
[GO] |
2021―Aug―08 |
Eligibility for live, interactive otolaryngology telemedicine: 19-Month experience before and during the COVID-19 pandemic in Taiwan |
Ching-Nung Wu, Sheng-Dean Luo, Hsin-Ching Lin, Jui-Ting Huang, Chih-Hung Lee, Song-Yan Liu, Ming-Hsien Tsai, Chih-Chi Wang, Sheng Fan, Pi-sheng Wang, Kuo-Chung Lan |
| 28 |
[GO] |
2021―Jul―13 |
Emerging mutation in SARS-CoV-2 spike: Widening distribution over time in different geographic areas |
Rosdiana Mus, Noviyanti Indjar Gama, Dwi Rahmaisyah, Riskah Nur'amalia |
| 29 |
[GO] |
2021―May―18 |
Integrative immunoinformatics paradigm for predicting potential B-cell and T-cell epitopes as viable candidates for subunit vaccine design against COVID-19 virulence |
Vyshnavie R. Sarma, Fisayo A. Olotu, Mahmoud E.S. Soliman |
| 30 |
[GO] |
2021―Apr―27 |
Author reply to the letter to the editor “Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19” |
Huey-Ling You, Chen-Hsiang Lee |
| 31 |
[GO] |
2021―Apr―20 |
COVID-19 fatal outcomes: role of the endothelial glycocalyx in both cell adhesion and migration |
Gerardo Tricarico, Valter Travagli |
| 32 |
[GO] |
2021―Apr―01 |
Realistic considerations for comparison between SARS-CoV-2 molecular diagnostic assays |
Kok-Siong Poon, Nancy Wen-Sim Tee |
| 33 |
[GO] |
2021―Feb―27 |
Metagenomic analysis of RNA-sequencing data reveals SARS-CoV-2 mediated changes in microbiota of upper respiratory tract |
Ganesan Velmurugan, Dinakaran Vasudevan |
| 34 |
[GO] |
2021―Feb―25 |
Artificial neural network and logistic regression modelling to characterize COVID-19 infected patients in local areas of Iran |
Farzaneh Mohammadi, Hamidreza Pourzamani, Hossein Karimi, Maryam Mohammadi, Mohammad Mohammadi, Nahid Ardalan, Roya Khoshravesh, Hassan Pooresmaeil, Samaneh Shahabi, Mostafa Sabahi, Fatemeh Sadat miryonesi, Marzieh Najafi, Zeynab Yavari, Farideh Mohammadi, Hakimeh Teiri, Mahsa Jannati |
| 35 |
[GO] |
2021―Feb―11 |
Dilemmas in Managing Acute Myocardial Infarction during Covid-19 Pandemic |
Meng-Yun Tsai, Ing-Kit Lee, Chia-Te Kung |
| 36 |
[GO] |
2021―Feb―10 |
Level Up for Culture Models - How 3D cell culture models benefit SARS-CoV-2 research |
Sophia Julia Häfner |
| 37 |
[GO] |
2021―Jan―28 |
Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation |
Wen-Fang Tang, Hui-Ping Tsai, Yu-Hsiu Chang, Tein-Yao Chang, Chung-Fan Hsieh, Chia-Yi Lin, Guan-Hua Lin, Yu-Li Chen, Jia-Rong Jheng, Ping-Cheng Liu, Chuen-Mi Yang, Yuan-Fan Chin, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Po-Shiuan Hsieh, Jim-Tong Horng |
| 38 |
[GO] |
2021―Jan―18 |
COVID-19 and gastrointestinal system: A brief review |
Akhil Pola, Karnam S. Murthy, Prasanna K. Santhekadur |
| 39 |
[GO] |
2020―Dec―29 |
Comparison of the Roche cobas 6800 SARS-CoV-2 test and the Taiwan CDC protocol for the molecular diagnosis of COVID-19 |
Huey-Ling You, Meng-Chih Lin, Chen-Hsiang Lee |
| 40 |
[GO] |
2020―Dec―10 |
Phytochemicals against SARS-CoV as potential drug leads |
Shasank Sekhar Swain, Sujogya Kumar Panda, Walter Luyten |
| 41 |
[GO] |
2020―Dec―07 |
Exploring algae and cyanobacteria as a promising natural source of antiviral drug against SARS-CoV-2 |
Neha Sami, Rakhshan Ahmad, Tasneem Fatma |
| 42 |
[GO] |
2020―Nov―25 |
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention |
Juan P. Jaworski |
| 43 |
[GO] |
2020―Nov―21 |
3D Culture Models to Study SARS-CoV-2 Infectivity and Antiviral Candidates: From Spheroids to Bioprinting |
Bruna A.G. de Melo, Julia C. Benincasa, Elisa M. Cruz, Juliana Terzi Maricato, Marimelia A. Porcionatto |
| 44 |
[GO] |
2020―Nov―10 |
Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment |
Paola Magro, Isabella Zanella, Marta Pescarolo, Francesco Castelli, Eugenia Quiros-Roldan |
| 45 |
[GO] |
2020―Oct―28 |
A review SARS-CoV-2 the other face to SARS-CoV and MERS-CoV: About future predictions |
T.M. Abdelghany, Magdah Ganash, Marwah M. Bakri, Nadeem I. Elhussieny, Husam Qanash, Aisha M.H. Al-Rajhi |
| 46 |
[GO] |
2020―Oct―24 |
Clinical features, laboratory findings and persistence of virus in 10 children with coronavirus disease 2019 (COVID-19) |
Hong Jiang, Hongbin Cheng, Qing Cao, Anxing Fei, Ming Yuan, Lixia Zhang, Shinuan Fei, Jun Li, Shixiong Yang, Jiang Wu, Qihua Fu, Sheng Li, Xiaoqing Zhang |
| 47 |
[GO] |
2020―Oct―01 |
Development of multi-epitope peptide-based vaccines against SARS-CoV-2 |
Hui Xuan Lim, Jianhua Lim, Seyed Davoud Jazayeri, Sibrandes Poppema, Chit Laa Poh |
| 48 |
[GO] |
2020―Sep―28 |
Application of Mesenchymal stem celland secretome for combating mortality and morbidity in COVID-19patients: A brief review |
Aditi Mahajan, Shalmoli Bhattacharyya |
| 49 |
[GO] |
2020―Sep―19 |
Expeditious responses to COVID-19 crisis: from governmental management to laboratory approach |
Huey-Kang Sytwu |
| 50 |
[GO] |
2020―Sep―03 |
Machine Learning Techniques for Sequence-based Prediction of Viral-Host Interactions between SARS-CoV-2 and Human Proteins |
Lopamudra Dey, Sanjay Chakraborty, Anirban Mukhopadhyay |
| 51 |
[GO] |
2020―Aug―27 |
Pandemic Number Five - Latest insights into the COVID-19 crisis |
Sophia Julia Häfner |
| 52 |
[GO] |
2020―Aug―24 |
Endothelial glycocalyx damage as a systemic inflammatory microvascular endotheliopathy in COVID-19 |
Minako Yamaoka-Tojo |
| 53 |
[GO] |
2020―Aug―11 |
Valinomycin as a potential antiviral agent against coronaviruses: a review |
Dong Zhang, Zhi Ma, Hanchi Chen, Yuele Lu, Xiaolong Chen |
| 54 |
[GO] |
2020―Jul―24 |
Current Updates on the European and WHO Registered Clinical Trials of Coronavirus Disease 2019 (COVID-19) |
Henu Kumar Verma, Neha Merchant, Manish Kumar Verma, Cansu İlke Kuru, Anand Narayan Singh, Fulden Ulucan, Poonam Verma, Antaripa Bhattacharya, L.V.K.S. Bhaskar |
| 55 |
[GO] |
2020―Jul―14 |
Concomitant infection with COVID-19 and Mycoplasma pneumoniae |
Allen Chung-Cheng Huang, Chung-Guei Huang, Cheng-Ta Yang, Han-Chung Hu |
| 56 |
[GO] |
2020―Jun―09 |
Rapid responses in the emergency department of Linkou Chang Gung Memorial Hospital, Taiwan effectively prevents spread of COVID-19 among healthcare workers of emergency department during outbreak: Lessons learnt from SARS |
Chen-June Seak, Ya-Tung Liu, Chip-Jin Ng |
| 57 |
[GO] |
2020―Jun―06 |
Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development |
Sheng-Wen Huang, Ching-Hui Tai, Yin-Mei Hsu, Dayna Cheng, Su-Jhen Hung, Kit Man Chai, Ya-Fang Wang, Jen-Ren Wang |
| 58 |
[GO] |
2020―Jun―01 |
Comprehensive review of coronavirus disease 2019 (COVID-19) |
Shaylika Chauhan |
| 59 |
[GO] |
2020―May―30 |
Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines |
Hsin-I Shih, Chi-Jung Wu, Yi-Fang Tu, Chia-Yu Chi |
| 60 |
[GO] |
2020―May―29 |
Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan |
Shiu-Feng Huang, Yhu-Chering Huang, Feng-Yee Chang, Jung-Chung Lin, Chun-Hsiang Chiu, Chien-Wen Chen, Fu-Der Wang, Yen-Ling Chiu, Shu-Hsing Cheng, Chien-Yu Cheng, Yi-Chun Lin, Cheng-Pin Chen, Chien-Hsien Huang, Po-Yu Liu, Yuan-Ti Lee, Chen-Hsiang Lee, Yao-Shen Chen, Cheng-Len Sy, Yu-Ting Tseng, Cheng-Ting Hsu, Chia-Chun Tseng, Yu-Lin Lee, Chun-Eng Liu, Huey-Kang Sytwu |
| 61 |
[GO] |
2020―May―29 |
Is there an association between oral health and severity of COVID-19 complications? |
Nathalie Botros, Parvati Iyer, David M. Ojcius |
| 62 |
[GO] |
2020―May―23 |
Repurposing old drugs as antiviral agents for coronaviruses |
Cheng-Wei Yang, Tzu-Ting Peng, Hsing-Yu Hsu, Yue-Zhi Lee, Szu-Huei Wu, Wen-Hsing Lin, Yi-Yu Ke, Tsu-An Hsu, Teng-Kuang Yeh, Wen-Zheng Huang, Jiunn-Horng Lin, Huey-Kang Sytwu, Chiung-Tong Chen, Shiow-Ju Lee |
| 63 |
[GO] |
2020―May―18 |
Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor |
Kushagra Dubey, Raghvendra Dubey |
| 64 |
[GO] |
2020―May―15 |
Artificial intelligence approach fighting COVID-19 with repurposing drugs |
Yi-Yu Ke, Tzu-Ting Peng, Teng-Kuang Yeh, Wen-Zheng Huang, Shao-En Chang, Szu-Huei Wu, Hui-Chen Hung, Tsu-An Hsu, Shiow-Ju Lee, Jeng-Shin Song, Wen-Hsing Lin, Tung-Jung Chiang, Jiunn-Horng Lin, Huey-Kang Sytwu, Chiung-Tong Chen |
| 65 |
[GO] |
2020―May―05 |
COVID-19: The first documented coronavirus pandemic in history |
Yen-Chin Liu, Rei-Lin Kuo, Shin-Ru Shih |
